PAUL D RUBIN Insider Trading $XOMA XOMA Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL D RUBIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL D RUBIN. PAUL D RUBIN is Sr. VP Clinical Dev. & CMO in XOMA Corp ($XOMA) and VP Clinical Dev. & CMO in XOMA Corp ($XOMA).
PAUL D RUBIN in XOMA Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL D RUBIN: Sr. VP Clinical Dev. & CMO, VP Clinical Dev. & CMO
Holdings: 72,021 shares
Current Value: $303,208
Latest Transaction: Dec 16 2014
$XOMA Market Capitalization: $25.10M
$XOMA Previous Close: $4.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL D RUBIN in XOMA Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 1,600 | 4,864 | 70,440 | |
| Dec 16 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.63 | 1,600 | 7,401 | 72,021 | 73.6 K to 72 K (-2.17 %) |
| Dec 16 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 1,600 | 4,864 | 73,621 | 72 K to 73.6 K (+2.22 %) |
| Nov 21 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 5,000 | 15,200 | 72,040 | |
| Nov 21 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.55 | 5,000 | 22,750 | 72,021 | 77 K to 72 K (-6.49 %) |
| Nov 21 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 5,000 | 15,200 | 77,021 | 72 K to 77 K (+6.94 %) |
| Oct 29 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 5,000 | 15,200 | 72,040 | |
| Oct 29 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.57 | 5,000 | 22,829 | 72,021 | 77 K to 72 K (-6.49 %) |
| Oct 29 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 5,000 | 15,200 | 77,021 | 72 K to 77 K (+6.94 %) |
| Sep 16 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 5,000 | 15,200 | 77,040 | |
| Sep 16 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.59 | 5,000 | 22,939 | 72,021 | 77 K to 72 K (-6.49 %) |
| Sep 16 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 5,000 | 15,200 | 77,021 | 72 K to 77 K (+6.94 %) |
| Sep 08 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 10,000 | 30,400 | 82,040 | |
| Sep 08 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.56 | 10,000 | 45,640 | 72,021 | 82 K to 72 K (-12.19 %) |
| Sep 08 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 10,000 | 30,400 | 82,021 | 72 K to 82 K (+13.88 %) |
| Aug 19 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 0.00 | 26,748 | 0 | 26,748 | |
| Aug 19 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.36 | 16,449 | 71,752 | 72,021 | 88.5 K to 72 K (-18.59 %) |
| Aug 19 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.31 | 10,299 | 44,341 | 88,470 | 98.8 K to 88.5 K (-10.43 %) |
| Aug 19 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 0.00 | 26,748 | 0 | 98,769 | 72 K to 98.8 K (+37.14 %) |
| Jun 18 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.54 | 11,580 | 52,595 | 72,021 | 83.6 K to 72 K (-13.85 %) |
| May 29 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 0.00 | 4,667 | 0 | 4,666 | |
| May 29 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.22 | 1,785 | 7,533 | 83,601 | 85.4 K to 83.6 K (-2.09 %) |
| May 29 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 0.00 | 4,667 | 0 | 85,386 | 80.7 K to 85.4 K (+5.78 %) |
| May 15 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 3.84 | 10,000 | 38,404 | 80,719 | 90.7 K to 80.7 K (-11.02 %) |
| Mar 20 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 0.00 | 18,205 | 0 | 18,205 | |
| Mar 20 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 0.00 | 12,142 | 0 | 24,282 | |
| Mar 20 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 6,000 | 18,240 | 92,040 | |
| Mar 20 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 6.31 | 6,000 | 37,848 | 90,719 | 96.7 K to 90.7 K (-6.20 %) |
| Mar 20 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 6,000 | 18,240 | 96,719 | 90.7 K to 96.7 K (+6.61 %) |
| Mar 20 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 6.32 | 6,988 | 44,136 | 90,719 | 97.7 K to 90.7 K (-7.15 %) |
| Mar 20 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 0.00 | 18,205 | 0 | 97,707 | 79.5 K to 97.7 K (+22.90 %) |
| Mar 20 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 6.32 | 4,661 | 29,439 | 79,502 | 84.2 K to 79.5 K (-5.54 %) |
| Mar 20 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 0.00 | 12,142 | 0 | 84,163 | 72 K to 84.2 K (+16.86 %) |
| Mar 03 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | A | 8.91 | 95,000 | 846,450 | 95,000 | |
| Mar 03 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Grant | A | 0.00 | 68,793 | 0 | 72,021 | 3.2 K to 72 K (+2,131.13 %) |
| Feb 19 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 6,000 | 18,240 | 98,040 | |
| Feb 19 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 7.55 | 6,000 | 45,272 | 3,228 | 9.2 K to 3.2 K (-65.02 %) |
| Feb 19 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 6,000 | 18,240 | 9,228 | 3.2 K to 9.2 K (+185.87 %) |
| Jan 23 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 5,694 | 17,310 | 104,040 | |
| Jan 23 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 8.27 | 5,694 | 47,078 | 3,228 | 8.9 K to 3.2 K (-63.82 %) |
| Jan 23 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 5,694 | 17,310 | 8,922 | 3.2 K to 8.9 K (+176.39 %) |
| Jan 23 2014 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 8.27 | 306 | 2,530 | 3,228 | 3.5 K to 3.2 K (-8.66 %) |
| Dec 18 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 6,000 | 18,240 | 109,734 | |
| Dec 18 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 5.67 | 6,000 | 33,992 | 3,534 | 9.5 K to 3.5 K (-62.93 %) |
| Dec 18 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 6,000 | 18,240 | 9,534 | 3.5 K to 9.5 K (+169.78 %) |
| Dec 02 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 4,696 | 14,276 | 115,734 | |
| Dec 02 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.54 | 4,696 | 21,320 | 3,534 | 8.2 K to 3.5 K (-57.06 %) |
| Dec 02 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 4,696 | 14,276 | 8,230 | 3.5 K to 8.2 K (+132.88 %) |
| Nov 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 2.36 | 1,304 | 3,077 | 15,887 | |
| Nov 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.08 | 1,304 | 5,317 | 3,534 | 4.8 K to 3.5 K (-26.95 %) |
| Nov 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 2.36 | 1,304 | 3,077 | 4,838 | 3.5 K to 4.8 K (+36.90 %) |
| Oct 21 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 2.36 | 746 | 1,761 | 17,191 | |
| Oct 21 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.71 | 746 | 3,511 | 8,788 | 9.5 K to 8.8 K (-7.82 %) |
| Oct 21 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 2.36 | 746 | 1,761 | 9,534 | 8.8 K to 9.5 K (+8.49 %) |
| Oct 02 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | L | 4.27 | 459 | 1,958 | 8,788 | 8.3 K to 8.8 K (+5.51 %) |
| Sep 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.53 | 6,000 | 27,187 | 8,329 | 14.3 K to 8.3 K (-41.87 %) |
| Aug 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 3.74 | 6,000 | 22,419 | 14,329 | 20.3 K to 14.3 K (-29.51 %) |
| Aug 16 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 0.00 | 26,748 | 0 | 53,496 | |
| Aug 16 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 3.86 | 10,520 | 40,621 | 20,329 | 30.8 K to 20.3 K (-34.10 %) |
| Aug 16 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 0.00 | 26,748 | 0 | 30,849 | 4.1 K to 30.8 K (+652.23 %) |
| Jul 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 2.36 | 2,748 | 6,485 | 17,937 | |
| Jul 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 3,252 | 9,886 | 120,430 | |
| Jul 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.71 | 3,252 | 15,302 | 4,101 | 7.4 K to 4.1 K (-44.23 %) |
| Jul 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 3,252 | 9,886 | 7,353 | 4.1 K to 7.4 K (+79.30 %) |
| Jul 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.71 | 2,748 | 12,931 | 4,101 | 6.8 K to 4.1 K (-40.12 %) |
| Jul 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 2.36 | 2,748 | 6,485 | 6,849 | 4.1 K to 6.8 K (+67.01 %) |
| Jul 01 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.45 | 567 | 1,955 | 4,101 | 3.5 K to 4.1 K (+16.04 %) |
| Jun 18 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 2.36 | 3,130 | 7,387 | 20,685 | |
| Jun 18 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 0.00 | 2,870 | 0 | 3,534 | 6.4 K to 3.5 K (-44.82 %) |
| Jun 18 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 0.00 | 3,130 | 0 | 6,404 | 9.5 K to 6.4 K (-32.83 %) |
| Jun 18 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 2.36 | 3,130 | 7,387 | 9,534 | 6.4 K to 9.5 K (+48.88 %) |
| May 29 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 0.00 | 4,667 | 0 | 9,333 | |
| May 29 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.16 | 1,797 | 7,476 | 6,404 | 8.2 K to 6.4 K (-21.91 %) |
| May 29 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 0.00 | 4,667 | 0 | 8,201 | 3.5 K to 8.2 K (+132.06 %) |
| May 21 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 2.36 | 785 | 1,853 | 23,815 | |
| May 21 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 0.00 | 5,215 | 0 | 3,534 | 8.7 K to 3.5 K (-59.61 %) |
| May 21 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.16 | 785 | 3,266 | 8,749 | 9.5 K to 8.7 K (-8.23 %) |
| May 21 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 2.36 | 785 | 1,853 | 9,534 | 8.7 K to 9.5 K (+8.97 %) |
| Apr 19 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 0.00 | 6,000 | 0 | 8,749 | 14.7 K to 8.7 K (-40.68 %) |
| Apr 01 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.32 | 1,498 | 4,967 | 14,749 | 13.3 K to 14.7 K (+11.30 %) |
| Mar 27 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 0.00 | 18,205 | 0 | 36,410 | |
| Mar 27 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 3.29 | 6,990 | 22,997 | 13,251 | 20.2 K to 13.3 K (-34.53 %) |
| Mar 27 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 0.00 | 18,205 | 0 | 20,241 | 2 K to 20.2 K (+894.16 %) |
| Mar 01 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | A | 0.00 | 36,424 | 0 | 36,424 | |
| Mar 01 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | A | 2.72 | 50,299 | 136,562 | 50,299 | |
| Jan 02 2013 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 2.28 | 833 | 1,899 | 2,036 | 1.2 K to 2 K (+69.24 %) |
| Oct 01 2012 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.51 | 542 | 1,900 | 1,203 | 661 to 1.2 K (+82.00 %) |
| Jul 23 2012 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | A | 0.00 | 80,244 | 0 | 80,244 | |
| Jul 23 2012 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | A | 3.53 | 110,813 | 391,170 | 110,813 | |
| Jul 02 2012 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 2.83 | 661 | 1,871 | 661 | 0 to 661 |
| Jul 02 2012 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Gift | G | 0.00 | 3,887 | 0 | 0 | 3.9 K to 0 (-100.00 %) |
| May 25 2012 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
| May 25 2012 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | A | 2.36 | 24,600 | 58,056 | 24,600 | |
| Apr 02 2012 | XOMA | XOMA Corp | RUBIN PAUL D | VP Clinical Dev. & ... | Buy | M | 2.63 | 1,229 | 3,234 | 3,887 | 2.7 K to 3.9 K (+46.24 %) |
| Feb 14 2012 | XOMA | XOMA Corp | RUBIN PAUL D | VP Clinical Dev. & ... | Option Exercise | A | 0.00 | 54,615 | 0 | 54,615 |
Page: 1